Compare gefurulimab PK exposure in healthy adults following a single subcutaneous (SC) dose administered by autoinjector versus manual prefilled syringe with safety device (PFS-SD). Safety, tolerability, immunogenicity, pharmacodynamics (PD), and device performance will also be assessed.
No takes yet. Share an insight, caveat, or question.
McEneny et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: